US BANCORP \DE\ - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$0
-100.0%
200
-41.3%
0.00%
Q3 2020$1,0000.0%341
+141.8%
0.00%
Q2 2020$1,000
-88.9%
141
-90.6%
0.00%
Q1 2018$9,000
+50.0%
1,500
+87.5%
0.00%
Q4 2017$6,0000.0%8000.0%0.00%
Q3 2017$6,000
+20.0%
8000.0%0.00%
Q2 2017$5,000
-28.6%
8000.0%0.00%
Q1 2017$7,0008000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders